Cargando…
New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
Niemann-Pick disease type C (NP-C) is an autosomal recessive disorder characterized by progressive neurological deterioration leading to premature death. The disease is caused by mutations in one of two genes, NPC1 or NPC2, leading to impaired intracellular lipid transport and build-up of lipids in...
Autores principales: | Wraith, James E, Imrie, Jackie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781062/ https://www.ncbi.nlm.nih.gov/pubmed/19956552 |
Ejemplares similares
-
Miglustat in Niemann-Pick disease type C patients: a review
por: Pineda, Mercè, et al.
Publicado: (2018) -
Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C
por: Héron, Bénédicte, et al.
Publicado: (2012) -
Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat
por: Walterfang, Mark, et al.
Publicado: (2012) -
Normalisation of brain spectroscopy findings in Niemann–Pick disease type C patients treated with miglustat
por: Sedel, Frédéric, et al.
Publicado: (2016) -
Long‐term survival outcomes of patients with Niemann‐Pick disease type C receiving miglustat treatment: A large retrospective observational study
por: Patterson, Marc C., et al.
Publicado: (2020)